quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:13:16·44d
INSIDERFiling
STAAR Surgical Company logo

SEC Form 4 filed by STAAR Surgical Company

STAA· STAAR Surgical Company
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • STAA
    STAAR Surgical Company
    Health Care

Recent analyst ratings

  • Apr 9UpdateCanaccord Genuity$27.00
  • Feb 3UpdateWedbush$26.00
  • Jan 16UpdateMorgan Stanley$13.00
  • Apr 21UpdateWells Fargo$17.00
  • Feb 12UpdateJefferies-
  • Feb 12UpdateMizuho$17.00

Related

  • ANALYST14d
    STAAR Surgical upgraded by Canaccord Genuity with a new price target
  • SEC15d
    STAAR Surgical Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR15d
    STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by STAAR Surgical Company
  • INSIDER38d
    Interim Co-CEO and Pres. & COO Foust Warren converted options into 37,500 shares, increasing direct ownership by 144% to 63,588 units (SEC Form 4)
  • INSIDER38d
    SEC Form 4 filed by Interim Co-CEO and CFO Andrews Deborah J
  • INSIDER38d
    Chief Development Officer Michna Magda converted options into 23,773 shares and covered exercise/tax liability with 8,529 shares, increasing direct ownership by 105% to 29,668 units (SEC Form 4)
  • INSIDER41d
    Director Broadwood Partners, L.P. bought $12,266,545 worth of shares (670,213 units at $18.30) (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022